PSS Guide 2023
Financial Support

Drugs for Carcinoid Syndrome

Find financial assistance programs available for carcinoid syndrome drugs.

Sandostatin LAR Depot (octreotide acetate) Injectable Suspension

Drug company: Novartis

Novartis Patient Assistance NOW Oncology provides 2 financial assistance programs for patients using Sandostatin LAR Depot:

Novartis Oncology Universal Co-pay Program

Novartis Patient Assistance Foundation

Somatuline Depot (lanreotide) Injection

Drug company: Ipsen

Ipsen Cares offers 2 financial assistance programs for patients using Somatuline Depot:

Somatuline Depot Virtual Copay Savings Program

Somatuline Depot Patient Assistance Program

Xermelo (telotristat ethyl) Tablets

Drug company: TerSera Therapeutics

TerSera Therapeutics offers 2 financial assistance programs for patients using Xermelo:

Xermelo Co-pay Program

TerSera Support Source

Table. Drugs Prescribed for Carcinoid Syndrome

  • Drug name (generic name)
  • Drug company
  • Indications
  • Patient support services

    Drug name (generic name)
  • Xermelo (telotristat ethyl) Tablets
  • Drug company
  • TerSera Therapeutics
  • Indication
  • Treatment of carcinoid syndrome diarrhea, in combination with a somatostatin analog
  • Patient support services
  • Xermelo Co-pay Program

    TerSera Support Source
Last modified: March 9, 2023

Report Broken Links

Have you encountered a problem with a URL (link) on this page not working or displaying an error message?

Help us fix it! Report broken links here.

Report Broken Link

Subscribe to Conquer: the journey informed

Receive timely cancer news & updates, patient stories, and more.

Race or Ethnicity
Profession or Role
Primary Interest
Other Interests